DECIPHERA PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.27 USD | -0.04% |
|
+72.26% | +56.66% |
Chart calendar Deciphera Pharmaceuticals, Inc.
c1.gf-gywfXIevjxJg2H3bNI-7EqhQXK5YVIbj1zcnzqlk.6s6NhzSxarOMl6BOUTmkU6-q2FJAcqZUcf-kh_-m7hHTjOGnYbpnna720Q~a13f677592b84c7db9acb57af4e2665d
Upcoming events on Deciphera Pharmaceuticals, Inc.
Past events on Deciphera Pharmaceuticals, Inc.
| Today | Q1 2024 Earnings Release (Projected) |
| 16/04/2024 16:30 | Stifel Virtual Targeted Oncology Days Conference |
| 13/03/2024 12:00 | Barclays Global Healthcare Conference |
| 11/03/2024 18:40 | Leerink Partners Global Biopharma Conference |
| 05/03/2024 18:30 | TD Cowen Health Care Conference |
| 08/02/2024 14:00 | Guggenheim Healthcare Talks Biotechnology Conference |
| 06/02/2024 13:00 | Q4 2023 Earnings Call |
| 06/02/2024 12:00 | Q4 2023 Earnings Release |
| 18/01/2024 19:45 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No - 748 |
| 10/01/2024 00:30 | JPMorgan Healthcare Conference |
| 06/12/2023 18:30 | JMP Securities Hematology and Oncology Summit |
| 29/11/2023 17:00 | Piper Sandler Healthcare Conference |
| 15/11/2023 18:50 | Stifel Healthcare Conference |
| 14/11/2023 16:00 | Jefferies London Healthcare Conference |
| 30/10/2023 12:00 | Q3 2023 Earnings Call - Vimseltinib Phase 3 Study Results Call |
| 30/10/2023 11:01 | Q3 2023 Earnings Release |
| 09/08/2023 13:00 | Q2 2023 Earnings Call |
| 09/08/2023 12:00 | Q2 2023 Earnings Release |
| 21/06/2023 13:30 | Annual General Meeting |
| 08/06/2023 19:30 | Jefferies Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 25,0 24,1 3.77% | 42,1 41,1 2.45% | 96,1 95,3 0.89% | 134 133 0.53% | 163 162 0.93% | 202 |
|
EBITDA Million USD | Released Forecast Spread | -200 -191 -4.54% | -269 -272 1.16% | -297 -304 2.33% | -180 -173 -3.92% | -209 -213 1.85% | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -201 -190 -5.72% | -271 -276 1.61% | -300 -299 -0.46% | -183 -180 -1.53% | -211 -214 1.61% | -203 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -192 -182 -5.38% | -266 -269 0.77% | -300 -308 2.52% | -178 -177 -0.56% | -195 -199 2.06% | -189 |
|
Net income Million USD | Released Forecast Spread | -192 -183 -5.3% | -266 -270 1.18% | -300 -298 -0.52% | -179 -177 -0.92% | -195 -199 1.99% | -196 |
|
EPS USD | Released Forecast Spread | -4,48 -4,15 -7.9% | -4,78 -4,84 1.33% | -5,16 -5,13 -0.54% | -2,37 -2,48 4.44% | -2,29 -2,34 2.14% | -2,18 |
| Announcement Date | 09/03/20 | 09/02/21 | 08/02/22 | 07/02/23 | 06/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 24,2 23,3 3.93% | 29,2 27,2 7.55% | 32,5 30,1 7.93% | 36,0 33,0 8.98% | 36,3 35,9 1.3% | 33,4 35,5 -5.78% | 38,3 36,3 5.47% | 43,3 39,2 10.42% | 48,3 46,8 3.19% | 46,2 | 48,7 | 52,7 | 54,0 | 48,6 |
|
EBITDA Million USD | Released Forecast Spread | -87,6 -95,0 7.77% | -46,1 -64,0 27.95% | -43,0 -46,0 6.59% | -44,1 -42,0 -5.09% | -46,6 -40,0 -16.4% | -52,6 -50,0 -5.3% | -50,8 -55,0 7.67% | |||||||
|
EBIT Million USD | Released Forecast Spread | -88,4 -87,0 -1.63% | -46,9 -50,2 6.62% | -43,8 -46,1 5.08% | -44,9 -44,2 -1.56% | -47,2 -44,5 -6.03% | -53,3 -49,0 -8.75% | -52,8 -52,7 -0.12% | -53,7 -54,8 2.08% | -51,2 -54,3 5.68% | -51,3 | -51,4 | -49,4 | -51,2 | -48,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -88,4 -96,0 7.95% | -46,9 -52,8 11.27% | -43,1 -45,8 6.05% | -43,0 -44,2 2.56% | -45,2 -44,2 -2.29% | -49,6 -48,6 -2.08% | -48,6 -51,2 5.17% | -49,6 -51,9 4.39% | -46,8 -49,5 5.54% | -48,5 | -48,0 | -45,4 | -47,1 | -44,1 |
|
Net income Million USD | Released Forecast Spread | -88,4 -86,8 -1.88% | -46,9 -50,2 6.56% | -43,1 -45,4 5.2% | -43,0 -43,7 1.46% | -45,9 -44,1 -4.2% | -49,6 -48,9 -1.55% | -48,6 -52,2 6.96% | -49,6 -52,4 5.4% | -47,2 -50,2 6.04% | -49,1 | -49,4 | -47,8 | -49,7 | -44,1 |
|
EPS USD | Released Forecast Spread | -1,51 -1,48 -2.02% | -0,80 -0,85 6.07% | -0,60 -0,66 8.55% | -0,55 -0,58 5.17% | -0,60 -0,56 -7.36% | -0,60 -0,59 -1.11% | -0,57 -0,62 8.43% | -0,58 -0,62 5.69% | -0,54 -0,58 7.1% | -0,56 | -0,56 | -0,52 | -0,54 | -0,46 |
| Announcement Date | 08/02/22 | 04/05/22 | 04/08/22 | 03/11/22 | 07/02/23 | 03/05/23 | 09/08/23 | 30/10/23 | 06/02/24 | - | - | - | - | - |
More events
Past sector events for Deciphera Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DCPH Stock
- Calendar Deciphera Pharmaceuticals, Inc.
